Medical screening Books
BenBella Books Lies I Taught in Medical School
Book Synopsis
£23.39
Oxford University Press Screening Evidence and Practice
Book SynopsisA comprehensive, practical, and accessible guide to screening programmes, for public health practitioners and anyone else involved in or with an interest in screening. It covers the concepts and evidence behind screening, how to make sound policy on screening, and how to plan and deliver high quality programmes at affordable cost.Trade ReviewThis is the best textbook I have ever read on all facets of an often hotly debated topic and "aha" experiences are guaranteed. If only everyone involved in the many screening debates had read this book, we would be having more constructive and useful discussions, and take better decisions. * Matthias Egger, University of Bern, Switzerland *A readable, yet encyclopaedic guide to screening: its history, its key design elements, its implementation and its policy challenges. A must read for clinicians, managers, and policy-makers who would like to assist Raffle, Mackie, and Gray in achieving their goal: "to sort out the mess". * H. Gilbert Welch, Dartmouth College, USA *Essential reading for anyone touched by screening, the new edition is not just a superficial update, it has been radically revised, and I commend it to all, whether or not they are familiar with the original. * Bob Steele, UK National Screening Committee *This welcome second edition contains new and updated material, and rigorous emphasis throughout ... I commend this book for academics as well as practitioners, and for those in clinical specialties as well as public health. * Iain Chalmers, James Lind Library, UK *Table of Contents1: How screening started 2: What screening is, and is not 3: What screening does 4: Measuring what a screening programme does 5: Implementing screening programmes 6: Quality assuring screening programmes 7: Day-to-day management of screening progammes for public health practitioners and managers 8: Making policy on screening programmes
£39.89
The University of Chicago Press Saving Babies
Book SynopsisDrawing on observations and interviews with families, doctors, and policy actors, this book presents an ethnographic study of how parents and geneticists resolve the many uncertainties in screening newborns. It is suitable for scholars of medicine, public health, and public policy.
£17.00
The University of Chicago Press Saving Babies
Book SynopsisSuitable for scholars of medicine, public health, and public policy, this title evaluates the consequences and benefits of state-mandated newborn screening - and the larger policy questions they raise about the inherent inequalities in American medical care that limit the effectiveness of this potentially lifesaving technology.Trade Review"Smart, humane, and beautifully written, Saving Babies? is respectful but critical of clinicians, parents, and policymakers as it vividly connects the reader to the human tragedies on the page. Without being maudlin, Stefan Timmermans and Mara Buchbinder show us how newborn screening really works. Despite the grim subjects, this profound book is a real treat to read." (Carol A. Heimer, Northwestern University)"
£80.00
John Wiley & Sons Inc Quantitative Imaging Tools for Lung Cancer Drug
Book SynopsisThis book presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise.Table of ContentsPreface (Thomas M. Baer and James L. Mulshine). Chapter 1: Incorporating Imaging into Drug Development: An Industry Perspective (Philip S. Murphy and Debasish Roychowdhury). Chapter 2: Developing Imaging Tools for Drug Development: Critical Technology, Clinical Data and Regulatory (Rafal Dziadziuszko, Fred R. Hirsch and Paul A. Bunn, Jr). Chapter 3: Quantitative Imaging in CT Lung Cancer Drug Development and Evaluation (Ricardo S. Avila). Chapter 4: Volumetric CT Imaging for Response Assessment in Lung Cancer: A Platform for Translational Research (Binsheng Zhao and Lawrence H. Scwhartz). Chapter 5: Emerging Radiological Software Standards and Development Technologies: Impact on Clinical Translation and Trials (John Pearson, Lawrence Tarbox, Gianluca Paladini, John G. Wolodzko, Paula M. Jacobs, and Zhenghong Lee). Chapter 6: Statistical Considerations Underlying Therapeutic Response Criteria for Lung Cancer: A Review in the Context of Emergence of Multi-Slice CT Scanner and Computer Assisted Diagnostic Algorithm for Volumetric Assessment (Madhu Mazumdar and Xi Kathy Zhou). Chapter 7: Programs Supporting Quantitative Imaging in Biomedicine at the National Institute for Standards and Technology (Thomas M. Baer and Charles W. Clark). Appendix A: Evolving Imaging Resources: Public Access Databases (Laurence Clarke). Appendix B: Biomedical Imaging Archive Network (Thomas M. Baer and James L. Mulshine). Appendix C: Developing CT Image-Processing Tools to Accelerate Progress in Lung Cancer Drug Development (James L. Mulshine, Ricardo S. Avila, Fred R. Hirsch, and David Yankelevitz).
£125.96
Rowman & Littlefield Publishers Is Prevention Better than Cure
Book Synopsis
£14.24
MD - Duke University Press Drugs for Life
Book SynopsisJoseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment.Trade Review"Drugs for Life is simply superb, a major accomplishment in the study of pharmaceuticals and their expanding relation to life itself. There is no recent scholarly work that attempts or accomplishes what Joseph Dumit does here, tackling the relation between big pharma and clinical epistemology in such a comprehensive and satisfying way. He deftly links critical debates across the life and human sciences, making an important and compelling argument on a matter central to contemporary public debate."—Lawrence Cohen, author of No Aging in India: Alzheimer’s, the Bad Family, and Other Modern Things"Drugs for Life shocks the reader into seeing health, medicine, pharmaceuticals, and the pharmaceutical industry and drug research for what they are from a cultural standpoint: a new framing of the future world for all of us. And that future is now and troubling and transformative of human conditions. A remarkable contribution that will perturb and disturb professional and general readers."—Arthur Kleinman, coeditor of Global Pharmaceuticals: Ethics, Markets, Practices"In this provocative and important book, Joseph Dumit brings a new approach to bear on critiques of the pharmaceutical industry and U.S. healthcare. He marshals ethnographic research among drug company executives and marketing strategists, along with the analysis of scientific and popular representations of their products, showing how consumers have been tutored into a proactive stance toward health. Over the past few decades, we have come to live by 'the numbers' and 'risk factors' that make embracing lifelong pharmaceutical regimes seem like common sense. But is it? Dumit explores the pharmaceuticalization of American culture and consciousness with a light, accessible touch that belies the depth of his knowledge."—Rayna Rapp, author of Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America“A rich and valuable contribution to literature on medical ethics, cultural studies, and the sociology of medicine. Highly recommended. Upper-division undergraduates and above.” -- A. W. Klink * Choice *“Drugs for Life is a synthetic achievement. It captures a web of phenomena occurring in disparate spaces—clinical research, treatment guidelines, advertising practices, biotechnology investments—and shows how they interact to reconfigure our intuitive, personal sense of what health is and what living requires. For this reason, it is destined to enter the canon of science and technology studies.” -- Helena Hansen * American Ethnologist *“Although its topic is an abstract one, much of Drugs for Life consists of insightful readings of advertisements, of statements by marketers and of patients' accounts. Dumit has pulled together a tremendous number of telling arguments and phrases, and can be at his best when reading them.” -- Sergio Sismondo * Times Higher Education *“Thought-provoking and chilling. . . . All registered nurses would . . . benefit from his analysis." -- Lucia Hwang * National Nurse *“Dumit examines the role played by the pharmaceutical industry and the rise of evidence-based medicine, which have redefined the borders between sickness and health along statistical lines. Drugs for Life is recommended for anyone who has ever been told they're at risk for illness.” -- Matt Savelli * Chemical Heritage *“Drugs for Life is a brilliant and provocative analysis of the new cultural and business logics of science, medicalization, and the drug industry.” -- Kristin Peterson * Somatosphere *“Drugs for Life is one of the best among many recent works on the pharmaceutical industry, and certainly the most sophisticated by the standards of science and technology studies.” -- Alasdair McMillan * Science as Culture *"Drugs for Life is a welcome addition to the fields of medical sociology, medical anthropology, the history of medicine, and STS more broadly. . . . Drugs for Life is provocative beyond the empirical area of pharmaceuticals. For example, scholars who research nondrug substances and materials will find in Drugs for Life a blueprint for success in the pharmaceutical industry that is provocative for understanding why not all products have this degree of ubiquity in the prevention of illness. Scholars who research medical equipment, devices, or tissues that exhibit druglike characteristics will find this work provocative." -- Krista Sigurdson * East Asian Science, Technology and Society *"[T]his book or one of its kind is an important read for those involved in the care of patients or the education of medical students or residents." -- William Ventres * Family Medicine *Table of ContentsAcknowledgments ix List of Illustrations xi Introduction 1 1. Responding to Facts 27 2. Pharmaceutical Witnessing and Direct-to-Consumer Advertising 55 3. Having to Grow Medicine 87 4. Mass Health: Illness Is a Line You Cross 105 5. Moving the Lines: Deciding on Thresholds 135 6. Knowing Your Numbers: Pharmaceutical Lifestyles 181 Conclusion. Living in a World of Surplus Health: Frequently Asked Questions 197 Notes 219 References 239 Index 257
£72.25
Duke University Press Drugs for Life
Book SynopsisJoseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment.Trade Review"Drugs for Life is simply superb, a major accomplishment in the study of pharmaceuticals and their expanding relation to life itself. There is no recent scholarly work that attempts or accomplishes what Joseph Dumit does here, tackling the relation between big pharma and clinical epistemology in such a comprehensive and satisfying way. He deftly links critical debates across the life and human sciences, making an important and compelling argument on a matter central to contemporary public debate."—Lawrence Cohen, author of No Aging in India: Alzheimer’s, the Bad Family, and Other Modern Things"Drugs for Life shocks the reader into seeing health, medicine, pharmaceuticals, and the pharmaceutical industry and drug research for what they are from a cultural standpoint: a new framing of the future world for all of us. And that future is now and troubling and transformative of human conditions. A remarkable contribution that will perturb and disturb professional and general readers."—Arthur Kleinman, coeditor of Global Pharmaceuticals: Ethics, Markets, Practices"In this provocative and important book, Joseph Dumit brings a new approach to bear on critiques of the pharmaceutical industry and U.S. healthcare. He marshals ethnographic research among drug company executives and marketing strategists, along with the analysis of scientific and popular representations of their products, showing how consumers have been tutored into a proactive stance toward health. Over the past few decades, we have come to live by 'the numbers' and 'risk factors' that make embracing lifelong pharmaceutical regimes seem like common sense. But is it? Dumit explores the pharmaceuticalization of American culture and consciousness with a light, accessible touch that belies the depth of his knowledge."—Rayna Rapp, author of Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America“A rich and valuable contribution to literature on medical ethics, cultural studies, and the sociology of medicine. Highly recommended. Upper-division undergraduates and above.” -- A. W. Klink * Choice *“Drugs for Life is a synthetic achievement. It captures a web of phenomena occurring in disparate spaces—clinical research, treatment guidelines, advertising practices, biotechnology investments—and shows how they interact to reconfigure our intuitive, personal sense of what health is and what living requires. For this reason, it is destined to enter the canon of science and technology studies.” -- Helena Hansen * American Ethnologist *“Although its topic is an abstract one, much of Drugs for Life consists of insightful readings of advertisements, of statements by marketers and of patients' accounts. Dumit has pulled together a tremendous number of telling arguments and phrases, and can be at his best when reading them.” -- Sergio Sismondo * Times Higher Education *“Thought-provoking and chilling. . . . All registered nurses would . . . benefit from his analysis." -- Lucia Hwang * National Nurse *“Dumit examines the role played by the pharmaceutical industry and the rise of evidence-based medicine, which have redefined the borders between sickness and health along statistical lines. Drugs for Life is recommended for anyone who has ever been told they're at risk for illness.” -- Matt Savelli * Chemical Heritage *“Drugs for Life is a brilliant and provocative analysis of the new cultural and business logics of science, medicalization, and the drug industry.” -- Kristin Peterson * Somatosphere *“Drugs for Life is one of the best among many recent works on the pharmaceutical industry, and certainly the most sophisticated by the standards of science and technology studies.” -- Alasdair McMillan * Science as Culture *"Drugs for Life is a welcome addition to the fields of medical sociology, medical anthropology, the history of medicine, and STS more broadly. . . . Drugs for Life is provocative beyond the empirical area of pharmaceuticals. For example, scholars who research nondrug substances and materials will find in Drugs for Life a blueprint for success in the pharmaceutical industry that is provocative for understanding why not all products have this degree of ubiquity in the prevention of illness. Scholars who research medical equipment, devices, or tissues that exhibit druglike characteristics will find this work provocative." -- Krista Sigurdson * East Asian Science, Technology and Society *"[T]his book or one of its kind is an important read for those involved in the care of patients or the education of medical students or residents." -- William Ventres * Family Medicine *Table of ContentsAcknowledgments ix List of Illustrations xi Introduction 1 1. Responding to Facts 27 2. Pharmaceutical Witnessing and Direct-to-Consumer Advertising 55 3. Having to Grow Medicine 87 4. Mass Health: Illness Is a Line You Cross 105 5. Moving the Lines: Deciding on Thresholds 135 6. Knowing Your Numbers: Pharmaceutical Lifestyles 181 Conclusion. Living in a World of Surplus Health: Frequently Asked Questions 197 Notes 219 References 239 Index 257
£19.79
Otago University Press Doctors in Denial
Book SynopsisWhen Dr Ron Jones joined the staff of National Womens Hospital in Auckland in 1973 as a junior obstetrician and gynaecologist, Professor Herbert Greens study into the natural history of carcinoma in-situ of the cervix (CIS) -- later called the unfortunate experiment -- had been in progress for seven years. By the mid-1960s there was almost universal agreement among gynaecologists and pathologists worldwide that CIS was a precursor of cancer, requiring complete removal. Green, however, believed otherwise, and embarked on a study of women with CIS, without their consent, that involved merely observing, rather than definitively treating them. Many women subsequently developed cancer and some died. In 1984 Jones and senior colleagues Dr Bill McIndoe and Dr Jock McLean published a scientific paper that exposed the truth, and the disastrous outcome of Greens experiment. In a public inquiry in 1987 Judge Sylvia Cartwright observed that an unethical experiment had been carried out in large num
£21.15
John Wiley and Sons Ltd Challenges in Prostate Cancer
Book SynopsisProstate cancer continues to be a major threat to men''s health, the second most common cancer in men, in many countries. Therefore it is increasingly important that those faced with difficult clinical questions make the right decisions. Since the first volume was published in 2000, many debates persist but new controversies have also emerged, reflected in the chapters of this new volume. New authors have been recruited to give their insight into newer areas of this controversial topic. Challenges in prostate cancer provides a series of state-of-the-art review articles, each of which addresses and answers a contentious question. It includes chapters on medical and surgical management of all stages of prostate cancer, clinical investigation, epidemiology, clinical trials and basic scientific research and covers issues such as the genetic basis of cancer, clinical economics and influence. The authors have used their expertise to distil the available evidence intoTrade Review"Currently there are more questions than answers in prostate cancer and the authors certainly could not have been expected to provide all the solutions for these many difficult issues. They have set out the problems clearly, however, and by doing so set a challenge for all of us in the urological community to provide the evidence based resolution to these many thorny issues by carefully constructed, long-term randomised files." British Journal of Urology "...contains useful information and is a helpful resource for understanding many of the controversies in this area." The LancetTable of ContentsList of contributors. Part 1: Biological and Scientific Aspects. 1 Tim Lane, Jon Strefford and Tim Oliver. An Update on Biotechnology in the Assessment of Prostate Cancer. 2 Ludger Barthelmes and Christopher A. Gateley. What Can We Learn From Breast Cancer?. 3 Bernhard Brehmer, Antonio Smakris and Gerhard Jakse. New Serum Markers for Prostate Cancer. 4 Kenichiro Ishii and Simon Hayward. The History of Tissue Recombination Technology: Current and Future Research. 5 Malcolm Mason and John Staffurth. Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?. Part 2: Diagnosis and Evaluation. 6 Bob Djavan, Michael Dobrovits and Michael Marberger. Equivocal PSAResults and Free Total PSARatio. 7 Murali Varma And David Griffiths . Equivocal Prostate Needle Biopsies. 8 Richard Clements. Prostate Biopsy: How Many Cores and Where From?. 9 Gail Beese and Christopher Edmunds. Counselling Patients With Early Prostate Cancer. 10 Owen Niall and Jamie Kearsley. The Role of Pelvic Node Dissection in Prostate Cancer. Part 3: Initial Treatment Policies. 11 Mark Wright. Laparoscopic Radical Prostatectomy. 12 A. Goyal and W. Bowsher. Endocrine Therapy for Prostate Cancer: the Latest. 13 Stijn De Vries, Christopher Bangma and Fritz Schröder. The Role of Conservative Policies in the Treatment of Prostate Cancer. 14 Gary Deng and Barrie Cassileth. Complementary and Alternative Therapies for Prostate Cancer. Part 4: Monitoring Progress and SecondaryTreatment. 15 Amir Kaisary. Radical Prostatectomy After Radical Radiotherapy. 16 Paul Jones and Neil Fenn. Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer. 17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatz and Michael L. Blute. Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?. 18 Leslie Moffat. Documenting Prostate Cancer: Epidemiology and Treatment. 19 Steven Oliver, Rhidian Hurle and Owen Hughes. Trends in Prostate Cancer Incidence and Mortality. 20 Jason Lester and E M Mahudson. Chemotherapy in Prostate Cancer. Index. Colour plates
£134.06
American Psychological Association Integrated Behavioral Health in Primary Care
Book SynopsisThis timely new edition of Integrated Behavioral Health in Primary Care brings the reader up to speed with changing aspects of primary care service delivery in response to the Patient-Centered Medical Home (PCMH), the Triple-Aim health approach, and the Patient Protection and Affordable Care Act.Table of ContentsContents List of Figures, Tables, and Exhibits Acknowledgments IntroductionPart I. Foundations of Integrated Behavioral Health Consultation Services Chapter 1. Population Health and the Patient-Centered Medical Home Chapter 2. Conducting the Initial Consultation Appointment Chapter 3. Common Behavioral and Cognitive Interventions in Primary Care Moving Out of the Specialty Mental Health ClinicPart II. Common Behavioral Health Concerns in Primary Care Chapter 4. Depression, Anxiety, Posttraumatic Stress Disorder, and Insomnia Chapter 5. Health Behaviors: Tobacco Use, Overweight and Obesity, and Physical Activity Chapter 6. Diabetes Chapter 7. Chronic Obstructive Pulmonary Disease and Asthma Chapter 8. Cardiovascular Disease Chapter 9. Pain Disorders Chapter 10. Alcohol and Prescription Medication Misuse Chapter 11. Sexual Problems Chapter 12. Special Considerations for Older Adults Chapter 13. Women’s Health Chapter 14. Children, Adolescents, and Parenting Chapter 15. Couple DistressPart III. Special Issues Chapter 16. Managing Suicide Risk in the Primary Care Setting Chapter 17. Clinical Pathways and Shared Medical Appointments References Index About the Authors
£82.80
Health Administration Press Accountable Care Organizations: Your Guide to
Book Synopsis
£78.30
American Occupational Therapy Screening Adult Neurologic Populations: A
Book SynopsisIn this era of managed health care and a focus on quality, the appropriate use of quick and cost-ef?cient screening methods has become critical in the assessment process. From brain injury to dementia, occupational therapists working with adults with neurological difficulties must be able to efficiently use various screening methods to pinpoint deficits and determine how they affect a client’s daily functioning.This update of the classic text is a functional, easy-to-understand instruction manual describing the most common screening methods for clients with neurological disorders. 10 primary areas of neurologic screening are presented: 1. Cognition 2. Vision 3. Perception 4. Sensation 5. Peripheral nerve function 6. Motor function (including deep tendon re?ex function) 7. Basal ganglia and cerebellar function (balance, postural control, automated movements) 8. Cranial nerve function 9. Dysphagia 10. Mental status. Each chapter includes functional implications of impairment, screening procedures, red flags (signs and symptoms), available in-depth assessments, and screening forms. Step-by-step instructions and extensive photographs guide clinicians through the screening process. Designed to allow therapists to easily identify possible impairment, document identi?ed dysfunction, and determine if further in-depth evaluation is warranted, this bestselling text is a valuable reference tool for students to take from the classroom to the clinic.
£112.80
OR Books Early Detection
Book SynopsisThe Second-Leading Killer in the USA Shouldn’t Be This Deadly Written by Bruce Ratner and Adam Bonislawski, …. Catching cancer early remains the single best way to combat a disease that is the second-leading killer in both the US and worldwide. But the vast majority of resources in the fight against cancer are devoted to relatively ineffective late stage treatments. ‘Early Detection’ examines this important anomaly in an accessible and expertly researched survey. In a co-authorship that brings together the passion and urgency of someone touched deeply by the experience of cancer with the knowledge of a skilled science writer, Ratner and Bonislawski narrate compelling case studies across a range of screening programs and different forms of cancer. In this book, you’ll discover: Importance of Early Detection: Understand the critical role early dete
£19.76
Royal Society of Chemistry Chemical Health Threats: Assessing and Alerting
Book SynopsisChemical health threats can have impacts across national borders and so may be more effectively tackled by international cooperation than by individual governments acting alone. As such, in November 2013, the European Union published the EU Decision for Serious Cross Border Threats to Health establishing a number of mechanisms for a coordinated, Europe-wide response with regards to preparedness, risk assessment, risk management, risk communication and international cooperation. Comprising a series of chapters from leading international researchers, this book covers recent developments in the field which support the implementation of these European legal instruments. It begins by contextualising the need for data that surveillance of toxic threats can deliver, before going on to examine some of the tools that have been developed to facilitate toxicosurveillance in Europe as well as current toxicosurveillance networks outside the EU. In addition, this book covers the European Union regulation concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), and the work of the Alerting System for Chemical Health Threats (ASHT) project to improve the risk assessment and management of chemical health threats in Europe. The volume provides a vital resource for researchers, educators, policy-makers and practitioners with an interest in key questions facing global hazardous substance control.Table of ContentsOverview of Alerting, Assessing and Responding to Chemical Public Health Threats; Chemical Regulation at the European Level: Safeguarding Consumer Health and Protecting the Environment; Medical Management of Mass Intoxications; Hazardous Exposures to Liquid Laundry Detergents Capsules in Young Children; Novel Applications of Spatial Mapping to Chemicals or Biological Outbreaks; Surveillance of Chemical Health Threats; Responding to New Psychoactive Substances in the Europen Union: Early Warning, Risk Assessment and Control Measures; Rapid Public Health Risk Assessments for Emerging Chemical Health Threats; Review of Risk Management Measures to Mitigate Against Exposures to Household Chemical Consumer Products; Understanding and Managing Behavioural and Psychological Responses to Chemical Incidents; Strategic, Technical and Scientific Advice in an Environmental Emergency; Public Health Preparation and Response to Chemical Incident Emergencies; Chemical Incident Management: An Overview of Preparedness, Response and Recovery; Investigating Outbreaks of Unknown Aetiology; Case Study: Methanol Mass Poisoning Outbreak in the Czech Republic: Diagnosis, Treatment and Outcome; Case Study: Fentanils: A Serious Threat to Public Health in Europe; Case Study: Enschede Fireworks Disaster: Lessons Learned; Case Study 4: The ANDE Fire, Paraguay, 2015
£170.05
Rutgers University Press Risk and Adaptation in a Cancer Cluster Town
Book SynopsisIn disease cluster communities across the country, environmental contamination from local industries is often suspected as a source of disease. But civic action is notoriously hampered by the slow response from government agencies to investigate the cause of disease and the complexities of risk assessment. In Risk and Adaptation in a Cancer Cluster Town, Laura Hart examines another understudied dimension of community inaction: the role of emotion and its relationship to community experiences of social belonging and inequality. Using a cancer cluster community in Northwest Ohio as a case study, Hart advances an approach to risk that grapples with the complexities of community belonging, disconnect, and disruption in the wake of suspected industrial pollution. Her research points to a fear driven not only by economic anxiety, but also by a fear of losing security within the community—a sort of pride that is not only about status, but connectedness. Hart reveals the importance of this social form of risk—the desire for belonging and the risk of not belonging—ultimately arguing that this is consequential to how people make judgements and respond to issues. Within this context where the imperative for self-protection is elusive, affected families experience psychosocial and practical conflicts as they adapt to cancer as a way of life. Considering a future where debates about risk and science will inevitably increase, Hart considers possibilities for the democratization of risk management and the need for transformative approaches to environmental justice.Trade Review“Hart does an excellent job weaving local community narratives in with sociological insights and theories of risk and belonging. Risk and Adaptation in a Cancer Cluster Town offers a clear and important contribution to in-depth community studies of industrial risks and environmental health disaster.” -- Peter Little * author of Toxic Town: IBM, Pollution, and Industrial Risks *“Hart’s account of Clyde, Ohio leaves the reader feeling as though they’ve come to know the residents of this town, and it skillfully captures the complexity underlying a community’s response to chronic contamination and illness. It is an important contribution to the literature on risk, disasters, and the sociology of emotions.” -- Norah MacKendrick * author of Better Safe Than Sorry: How Consumers Navigate their Exposure to Everyday Toxics *Table of Contents Preface and Acknowledgments Introduction: The Town of Whirlpool 1 The Deregulation of Toxic Chemicals 2 Cancer in Clyde and “Will-o’-the-Wisp Things” 3 Emotion, Risk, and Othering 4 Embodied Risk 5 Toward Transformative Movements of Theory and Practice Notes Index
£23.39
Rutgers University Press Risk and Adaptation in a Cancer Cluster Town
Book SynopsisIn disease cluster communities across the country, environmental contamination from local industries is often suspected as a source of disease. But civic action is notoriously hampered by the slow response from government agencies to investigate the cause of disease and the complexities of risk assessment. In Risk and Adaptation in a Cancer Cluster Town, Laura Hart examines another understudied dimension of community inaction: the role of emotion and its relationship to community experiences of social belonging and inequality. Using a cancer cluster community in Northwest Ohio as a case study, Hart advances an approach to risk that grapples with the complexities of community belonging, disconnect, and disruption in the wake of suspected industrial pollution. Her research points to a fear driven not only by economic anxiety, but also by a fear of losing security within the community—a sort of pride that is not only about status, but connectedness. Hart reveals the importance of this social form of risk—the desire for belonging and the risk of not belonging—ultimately arguing that this is consequential to how people make judgements and respond to issues. Within this context where the imperative for self-protection is elusive, affected families experience psychosocial and practical conflicts as they adapt to cancer as a way of life. Considering a future where debates about risk and science will inevitably increase, Hart considers possibilities for the democratization of risk management and the need for transformative approaches to environmental justice.Trade Review“Hart does an excellent job weaving local community narratives in with sociological insights and theories of risk and belonging. Risk and Adaptation in a Cancer Cluster Town offers a clear and important contribution to in-depth community studies of industrial risks and environmental health disaster.” -- Peter Little * author of Toxic Town: IBM, Pollution, and Industrial Risks *“Hart’s account of Clyde, Ohio leaves the reader feeling as though they’ve come to know the residents of this town, and it skillfully captures the complexity underlying a community’s response to chronic contamination and illness. It is an important contribution to the literature on risk, disasters, and the sociology of emotions.” -- Norah MacKendrick * author of Better Safe Than Sorry: How Consumers Navigate their Exposure to Everyday Toxics *Table of Contents Preface and Acknowledgments Introduction: The Town of Whirlpool 1 The Deregulation of Toxic Chemicals 2 Cancer in Clyde and “Will-o’-the-Wisp Things” 3 Emotion, Risk, and Othering 4 Embodied Risk 5 Toward Transformative Movements of Theory and Practice Notes Index
£107.20
Rutgers University Press Mammography Wars: Analyzing Attention in Cultural
Book SynopsisMammography is a routine health screening performed forty million times each year in the United States, yet it remains one of the most deeply contested topics in medicine, with national health care organizations supporting conflicting guidelines. In Mammography Wars, sociologist Asia Friedman examines cultural and medical disagreements over mammography. At issue is whether to screen women under age fifty, which is rooted in deeper questions about early detection and the assumed linear and progressive development of breast cancer. Based on interviews with doctors and scientists, interviews with women ages 40 to 50, and newspaper coverage of mammography, Friedman uses the sociology of attention to map the cognitive structure of the “mammography wars,” offering insights into the entrenched nature of debates over mammography that often get missed when applying a medical lens. Friedman’s analysis also suggests the sociology of attention’s unique potential for analyzing cultural conflicts beyond mammography, and even beyond medicine. Trade Review“Friedman is a thorough researcher with a clear, engaging style. Her focus on patterns of attention as the organizing analytical framework is fresh and unusual: a fascinating read.” -- Kelly Joyce * professor of sociology, Drexel University *“Mammography Wars is an insightful intervention into deeply entrenched conflict surrounding mammography screening standards in the United States. Friedman deftly blends together empirical analysis of the narratives driving disagreements among professionals and patients alike with a clear and accessible take on the power of the sociology of attention, breaking through seemingly intractable ideological battles to resolve conflict.” -- Piper Sledge * author of Bodies Unbound: Gender-Specific Cancer and Biolegitimacy *Table of Contents Introduction: The Mammography Wars Chapter 1: Skepticism and Interventionism as Attentional Types Chapter 2: Attentional Diversity—The Cognitive Structure of Patients’ Narratives of Mammography Chapter 3: Attentional Battles over Mammography Chapter 4: Attentional Weight—Relevance, Risk, and Expertise in Mammography Chapter 5: Mammography and Time Conclusion: Attentional Flexibility Appendix Acknowledgements Notes References Index
£32.30
Rutgers University Press Mammography Wars: Analyzing Attention in Cultural
Book SynopsisMammography is a routine health screening performed forty million times each year in the United States, yet it remains one of the most deeply contested topics in medicine, with national health care organizations supporting conflicting guidelines. In Mammography Wars, sociologist Asia Friedman examines cultural and medical disagreements over mammography. At issue is whether to screen women under age fifty, which is rooted in deeper questions about early detection and the assumed linear and progressive development of breast cancer. Based on interviews with doctors and scientists, interviews with women ages 40 to 50, and newspaper coverage of mammography, Friedman uses the sociology of attention to map the cognitive structure of the “mammography wars,” offering insights into the entrenched nature of debates over mammography that often get missed when applying a medical lens. Friedman’s analysis also suggests the sociology of attention’s unique potential for analyzing cultural conflicts beyond mammography, and even beyond medicine. Trade Review“Friedman is a thorough researcher with a clear, engaging style. Her focus on patterns of attention as the organizing analytical framework is fresh and unusual: a fascinating read.” -- Kelly Joyce * professor of sociology, Drexel University *“Mammography Wars is an insightful intervention into deeply entrenched conflict surrounding mammography screening standards in the United States. Friedman deftly blends together empirical analysis of the narratives driving disagreements among professionals and patients alike with a clear and accessible take on the power of the sociology of attention, breaking through seemingly intractable ideological battles to resolve conflict.” -- Piper Sledge * author of Bodies Unbound: Gender-Specific Cancer and Biolegitimacy *Table of Contents Introduction: The Mammography Wars Chapter 1: Skepticism and Interventionism as Attentional Types Chapter 2: Attentional Diversity—The Cognitive Structure of Patients’ Narratives of Mammography Chapter 3: Attentional Battles over Mammography Chapter 4: Attentional Weight—Relevance, Risk, and Expertise in Mammography Chapter 5: Mammography and Time Conclusion: Attentional Flexibility Appendix Acknowledgements Notes References Index
£107.20
John Libbey Eurotext Parliaments & Screening: Ethical & Social
Book SynopsisWhat should Parliaments do about screening for AIDS and detecting genetic diseases? How do the media report and comment on information in this field? Twelve papers commissioned from national parliamentarians and parliamentary staff from the then twelve member states of the Union describe how information about the progress and potentialities of the revolution in human microbiology, and its actual and potential ethical and social effects, is at present acquired and handled.
£22.49
Springer Nature Switzerland AG Assessment of Cancer Screening: A Primer
Book SynopsisCancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years.Table of ContentsFoundations.- Behind the scenes.- Performance measures.- Population measures: definitions.- Population measures: cancer screening’s impact.- Experimental research designs.- Observational research designs.- Cancer prevention screening.- Additional considerations.- Closing thoughts
£33.24
De Gruyter Das Fetale Alkoholsyndrom: Im Kindes- Und
Book Synopsis
£82.65
World Health Organization Who Human Health Risk Assessment Toolkit:
Book Synopsis
£31.90
World Health Organization Health Environment: Managing the Linkages for
Book Synopsis
£22.79
World Health Organization Informe Sobre La Salud En El Mundo 2013:
Book Synopsis
£45.60
Pan American Health Organization Familias Fuertes--Amor Y Límites: Guía Para La
Book Synopsis
£31.50
IARC Some Industrial Chemicals: IARC Monographs on the
Book Synopsis
£59.40
WHO Regional Office for Europe Preventing Injuries in Europe: From International
Book Synopsis
£29.45
WHO Regional Office for Europe Health Risks of Ozone from Long-Range
Book Synopsis
£22.54
WHO Regional Office for the Eastern Mediterranean Social Determinants of Health in Countries in
Book Synopsis
£18.43
Jaypee Brothers Medical Publishers Differential Screening of Regional Pain in
Book SynopsisDifferential Screening of Regional Pain in Musculoskeletal Practice covers screening across the musculoskeletal system, outlining the biochemical basis for pain. This book is written by US based physical therapist, osteopath and naturopath, Deepak Sebastian. Comprised of ten chapters covering each different region of the musculoskeletal system, this book begins with an introduction and discussion of thought process in regional pain. The second chapter investigates the chemical basis of the human body in relation to pain, with the third covering drug-induced regional pain. Subsequent chapters cover specific regions in detail including cervical, thoracic, lumbopelvic, hip, knee, ankle, foot, shoulder, elbow, and wrist and hand pain. Enhanced by 116 images and illustrations, Differential Screening of Regional Pain in Musculoskeletal Practice is an excellent reference guide for physical therapists who need to identify a set of conditions or diagnoses for specific regional pain symptoms. Key Points Reference guide for physical therapists diagnosing symptoms of pain in the musculoskeletal system 116 illustrations and images Written by US based physical therapist Deepak Sebastian Table of Contents Introduction and Thought Process in Regional Pain Chemical Basis of the Human Body with Relevance to Regional Musculoskeletal Pain Drug-induced Regional Pain Cervical Pain Thoracic Pain Lumbopelvic Pain Hip Pain Knee, Ankle and Foot Pain Shoulder Pain Elbow, Wrist and Hand Pain Index
£105.30
Bootlegged Publishing Het Wuhan coronavirus veiligheidshandboek: De
Book Synopsis
£7.49
